The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update.

MLA

Boccardi, Marina, et al. “The Strategic Biomarker Roadmap for the Validation of Alzheimer’s Diagnostic Biomarkers: Methodological Update.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 48, no. 7, July 2021, pp. 2070–85. EBSCOhost, https://doi.org/10.1007/s00259-020-05120-2.

APA

Boccardi, M., Dodich, A., Albanese, E., Gayet-Ageron, A., Festari, C., Ashton, N. J., Bischof, G. N., Chiotis, K., Leuzy, A., Wolters, E. E., Walter, M. A., Rabinovici, G. D., Carrillo, M., Drzezga, A., Hansson, O., Nordberg, A., Ossenkoppele, R., Villemagne, V. L., Winblad, B., & Frisoni, G. B. (2021). The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update. European Journal of Nuclear Medicine & Molecular Imaging, 48(7), 2070–2085. https://doi.org/10.1007/s00259-020-05120-2

Chicago

Boccardi, Marina, Alessandra Dodich, Emiliano Albanese, Angèle Gayet-Ageron, Cristina Festari, Nicholas J. Ashton, Gérard N. Bischof, et al. 2021. “The Strategic Biomarker Roadmap for the Validation of Alzheimer’s Diagnostic Biomarkers: Methodological Update.” European Journal of Nuclear Medicine & Molecular Imaging 48 (7): 2070–85. doi:10.1007/s00259-020-05120-2.